Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China · Delayed Price · Currency is CNY 13.87
+0.14 (1.02%)
Nov 6, 2026, 9:25 AM CST
SHA:603896 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 634.65 | 778.39 | 854.03 | 1,504 | 1,525 | 677.98 |
Trading Asset Securities | 359.92 | 356.16 | 344.69 | - | 30 | 130 |
Cash & Short-Term Investments | 994.57 | 1,135 | 1,199 | 1,504 | 1,555 | 807.98 |
Cash Growth | -7.84% | -5.35% | -20.30% | -3.26% | 92.42% | 12.34% |
Accounts Receivable | 77.66 | 94.09 | 114.72 | 113.06 | 137.68 | 117.25 |
Other Receivables | 3.55 | 3.87 | 3.15 | 3.25 | 2.51 | 3.36 |
Receivables | 81.21 | 97.95 | 117.87 | 116.32 | 140.19 | 120.61 |
Inventory | 255.46 | 208.91 | 181.69 | 157.83 | 147.76 | 99.06 |
Other Current Assets | 36.12 | 29.14 | 22.37 | 28.73 | 19.35 | 17.64 |
Total Current Assets | 1,367 | 1,471 | 1,521 | 1,807 | 1,862 | 1,045 |
Property, Plant & Equipment | 1,156 | 1,111 | 916.38 | 682.32 | 601.14 | 515.91 |
Long-Term Investments | 109.32 | 102.67 | 94.85 | 65.71 | 63.8 | 66.46 |
Other Intangible Assets | 346.36 | 354.28 | 352.86 | 310.98 | 78.16 | 82.98 |
Long-Term Deferred Tax Assets | 1.36 | 1.69 | - | - | - | 0.37 |
Long-Term Deferred Charges | 53.91 | 73.81 | 68.82 | 79.78 | 53.13 | 39.93 |
Other Long-Term Assets | 162.15 | 167.42 | 178.24 | 228.71 | 197.94 | 211.51 |
Total Assets | 3,196 | 3,282 | 3,132 | 3,174 | 2,856 | 1,962 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 149.22 | 154.78 | 132.86 | 132.71 | 103.98 | 107.94 |
Accrued Expenses | 19.58 | 65.66 | 37.56 | 40.28 | 71.15 | 54.03 |
Short-Term Debt | 183.93 | 194.04 | 187.4 | 372.16 | 272.97 | - |
Current Portion of Leases | - | 17.45 | 16.77 | 12.08 | 4.87 | 5.63 |
Current Income Taxes Payable | 9.37 | 85.64 | - | 0.02 | 0.24 | 0.02 |
Current Unearned Revenue | 12.99 | 14.96 | 11.74 | 10.1 | 9.03 | 9.61 |
Other Current Liabilities | 13.13 | 13.3 | 7 | 17.79 | 15.53 | 22.05 |
Total Current Liabilities | 401.21 | 545.83 | 393.33 | 585.15 | 477.77 | 199.28 |
Long-Term Debt | 402.53 | 382.49 | 361.01 | 340.19 | 412.59 | 87.6 |
Long-Term Leases | 18.76 | 21 | 22.93 | 23.97 | 15.97 | 13.33 |
Long-Term Unearned Revenue | 55.06 | 62.13 | 54.86 | 49.98 | 41.3 | 38.23 |
Long-Term Deferred Tax Liabilities | 10.77 | 9.64 | 8.39 | 3.78 | 3.04 | 3.98 |
Total Liabilities | 888.33 | 1,021 | 840.52 | 1,003 | 950.67 | 342.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 198.24 | 198.24 | 198.24 | 201.83 | 197.2 | 152.5 |
Additional Paid-In Capital | 818.22 | 818.22 | 821.52 | 966.03 | 856.25 | 900.22 |
Retained Earnings | 1,158 | 1,118 | 1,153 | 1,076 | 908.45 | 690.99 |
Treasury Stock | - | - | - | -165.11 | -165.11 | -165.11 |
Comprehensive Income & Other | 131.16 | 125.23 | 118.15 | 92.83 | 108.73 | 41.06 |
Total Common Equity | 2,306 | 2,260 | 2,291 | 2,171 | 1,906 | 1,620 |
Minority Interest | 1.65 | 0.93 | - | - | - | 0.38 |
Shareholders' Equity | 2,308 | 2,260 | 2,291 | 2,171 | 1,906 | 1,620 |
Total Liabilities & Equity | 3,196 | 3,282 | 3,132 | 3,174 | 2,856 | 1,962 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 618.22 | 614.98 | 588.11 | 748.4 | 706.41 | 106.56 |
Net Cash (Debt) | 376.35 | 519.57 | 610.61 | 755.56 | 848.31 | 701.42 |
Net Cash Growth | -25.73% | -14.91% | -19.18% | -10.93% | 20.94% | 32.06% |
Net Cash Per Share | 1.81 | 2.57 | 3.08 | 3.86 | 4.37 | 3.67 |
Filing Date Shares Outstanding | 221.47 | 198.24 | 198.24 | 198.24 | 197.2 | 198.25 |
Total Common Shares Outstanding | 221.47 | 198.24 | 198.24 | 198.24 | 197.2 | 198.25 |
Working Capital | 966.14 | 924.72 | 1,127 | 1,222 | 1,384 | 846.02 |
Book Value Per Share | 10.41 | 11.40 | 11.56 | 10.95 | 9.66 | 8.17 |
Tangible Book Value | 1,960 | 1,905 | 1,938 | 1,860 | 1,827 | 1,537 |
Tangible Book Value Per Share | 8.85 | 9.61 | 9.78 | 9.38 | 9.27 | 7.75 |
Buildings | - | 858.76 | 350.9 | 308.29 | 357.46 | 355.62 |
Machinery | - | 305 | 251.39 | 241.18 | 198.58 | 145.46 |
Construction In Progress | - | 192.72 | 501.72 | 280.21 | 169.63 | 115.34 |